Ultrasound-guided Microwave Ablation in the Treatment of Recurrent Primary Hyperparathyroidism in a Patient with MEN1: a Case Report

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Oct 5

PMID 37795364

Authors

Zhoujun Liu

Yueting Zhao

Xue Han

Xin Hu

Yuzhi Zhang

Lan Xu

Guofang Chen

Chao Liu

Shuhang Xu

Affiliations

Soon will be listed here.

Abstract

Background: Multiple endocrine neoplasia type 1 (MEN1) is an inherited endocrine syndrome caused by the mutation in the tumor suppressor gene . The recurrence rate of primary hyperparathyroidism (PHPT) in patients with MEN1 after parathyroidectomy remains high, and the management of recurrent hyperparathyroidism is still challenging.

Case Presentation: We reported a 44-year-old woman with MEN1 combined with PHPT who was diagnosed through genetic screening of the patient and her family members. After parathyroidectomy to remove one parathyroid gland, the patient suffered from persistent high levels of serum calcium and parathyroid hormone, which returned to normal at up to 8 months after ultrasound-guided microwave ablation (MWA) for bilateral parathyroid glands, suggesting an acceptable short-term prognosis.

Conclusion: Ultrasound-guided MWA for parathyroid nodules may be an effective therapeutic strategy for recurrent PHPT in MEN1 patients.

References

Walker M, Silverberg S . Primary hyperparathyroidism. Nat Rev Endocrinol. 2017; 14(2):115-125. PMC: 6037987. DOI: 10.1038/nrendo.2017.104. View

Thakker R, Newey P, Walls G, Bilezikian J, Dralle H, Ebeling P . Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012; 97(9):2990-3011. DOI: 10.1210/jc.2012-1230. View

Hellman P, Skogseid B, Oberg K, Juhlin C, Akerstrom G, Rastad J . Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery. 1998; 124(6):993-9. View

Kraimps J, Duh Q, Demeure M, Clark O . Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery. 1992; 112(6):1080-6; discussion 1086-8. View

Nastos C, Papaconstantinou D, Kofopoulos-Lymperis E, Peppa M, Pikoulis A, Lykoudis P . Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis. Surgery. 2020; 169(2):302-310. DOI: 10.1016/j.surg.2020.08.021. View

Manoharan J, Albers M, Bollmann C, Maurer E, Mintziras I, Wachter S . Single gland excision for MEN1-associated primary hyperparathyroidism. Clin Endocrinol (Oxf). 2019; 92(1):63-70. DOI: 10.1111/cen.14112. View

Ospina N, Thompson G, Lee R, Reading C, Young Jr W . Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2014; 100(1):E87-90. DOI: 10.1210/jc.2014-3255. View

Kivlen M, Bartlett D, Libutti S, Skarulis M, Marx S, Simonds W . Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2001; 130(6):991-8. DOI: 10.1067/msy.2001.118379. View

Yazdani A, Khalili N, Siavash M, Shemian A, Goharian A, Karimifar M . Ultrasound-guided ethanol injection for the treatment of parathyroid adenoma: A prospective self-controlled study. J Res Med Sci. 2020; 25:93. PMC: 7698383. DOI: 10.4103/jrms.JRMS_553_19. View

10.

Choi H, Choi S, Choi S, Kim J, Lee C, Kang S . Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism. Sci Rep. 2020; 10(1):10634. PMC: 7326992. DOI: 10.1038/s41598-020-67424-5. View

11.

Alherabi A, Marglani O, Alfiky M, Raslan M, Al-Shehri B . Percutaneous ultrasound-guided alcohol ablation of solitary parathyroid adenoma in a patient with primary hyperparathyroidism. Am J Otolaryngol. 2015; 36(5):701-3. DOI: 10.1016/j.amjoto.2015.04.006. View

12.

Hubbard J, Sebag F, Maweja S, Henry J . Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 2006; 141(3):235-9. DOI: 10.1001/archsurg.141.3.235. View

13.

Versnick M, Popadich A, Sidhu S, Sywak M, Robinson B, Delbridge L . Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism. Surgery. 2013; 154(1):101-5. DOI: 10.1016/j.surg.2013.03.004. View

14.

Wei Y, Peng L, Li Y, Zhao Z, Yu M . Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism. Korean J Radiol. 2020; 21(5):572-581. PMC: 7183824. DOI: 10.3348/kjr.2019.0593. View

15.

Veldman M, Reading C, Farrell M, Mullan B, Wermers R, Grant C . Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1. AJR Am J Roentgenol. 2008; 191(6):1740-4. DOI: 10.2214/AJR.07.3431. View

16.

Ni W, Yuan Y, Chu X, Chen G, Han X, Li J . Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism. Front Endocrinol (Lausanne). 2021; 12:782050. PMC: 8672162. DOI: 10.3389/fendo.2021.782050. View

17.

Kluijfhout W, Beninato T, Drake F, Vriens M, Gosnell J, Shen W . Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. World J Surg. 2016; 40(12):2964-2969. PMC: 5104782. DOI: 10.1007/s00268-016-3624-9. View

18.

Lairmore T, Govednik C, Quinn C, Sigmond B, Lee C, Jupiter D . A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2014; 156(6):1326-34. DOI: 10.1016/j.surg.2014.08.006. View

19.

Lee D, Walker M, Chen H, Chabot J, Lee J, Kuo J . Bone mineral density changes after parathyroidectomy are dependent on biochemical profile. Surgery. 2018; 165(1):107-113. DOI: 10.1016/j.surg.2018.04.065. View

20.

Waldmann J, Lopez C, Langer P, Rothmund M, Bartsch D . Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. Br J Surg. 2010; 97(10):1528-34. DOI: 10.1002/bjs.7154. View